Mauna Kea Technologies receives CE Mark for Cellvizio in minimally invasive surgery

Mauna Kea Technologies’ Cellvizio technology has received a CE mark for use in minimally invasive laparoscopic surgical indications.

Advertisement

Cellvizio is designed to provide real-time visualization of tissue at the microscopic level. Through the expanded indication in Europe, Cellvizio could now be used in a wide range of oncologic surgical procedures.

More articles on gastroenterology:
9 gastroenterologists selected for ASGE’s ACE Program
Commonwealth Laboratories launches IBS blood test
Virginia Mason joins lawsuit against Olympus America – 5 key notes

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.